The chemistry and pharmacology of anatoxin-a and related homotropanes with respect to nicotinic acetylcholine receptors

Marine Drugs

Volumn 4, Issue 3, 2006, Pages 228-254

  Wonnacott, Susan ^a   Gallagher, Timothy ^b  

^a University of Bath   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Anatoxin a; Homoanatoxin; Homotropane; Nicotinic acetylcholine receptor; Pharmacophore; Pinnamine; UB165

Indexed keywords

ANATOXIN A; HOMOANATOXIN; MARINE TOXIN; NICOTINIC RECEPTOR; PINNAMINE; UB 165; UNCLASSIFIED DRUG;

DRUG ISOLATION; DRUG STRUCTURE; DRUG SYNTHESIS; MEDICAL RESEARCH; PHARMACOPHORE; REVIEW;

EID: 33646786810     PISSN: 16603397     EISSN: 16603397     Source Type: Journal    
DOI: 10.3390/md403228     Document Type: Review

References (79)

1. Francis, G. Poisonous Australian Lake. Nature 1878, 11-12.
2. James, K. J.; Crowley, J.; Hamilton, B.; Lehane, M.; Skulberg, O.; Furey, A. Anatoxins and degradation products, determined using hybrid quadrupole time-of-flight and quadrupole ion-trap mass spectrometry: forensic investigations of cyanobacterial neurotoxin poisoning. Rapid Commun. Mass Spectrom. 2005, 19, 1167-1175.
3. James, K. J.; Furey, A.; Sherlock, I. R.; Stack, M. A.; Twohig, M.; Caudwell, F. B.; Skulberg, O. M. Sensitive determination of anatoxin-a, homoanatoxin-a and their degradation products by liquid chromatography with fluorimetric detection. J. Chromatogr. A 1998, 798, 147-157.
4. Drager, B. Analysis of tropane and related alkaloids. J. Chromatogr. A 2002, 978, 1-35.
5. Pravda, M.; Kreuzer, M. P.; Guilbault, G. G. Analysis of important freshwater and marine toxins. Anal. Lett. 2002, 35, 1-15.
6. Mansell, H. L. Synthetic approaches to anatoxin-a. Tetrahedron 1996, 52, 6025-6061.
7. Karlin, A. Emerging structure of the nicotinic acetylcholine receptors. Nat. Rev. Neurosci. 2002, 3, 102-114.
8. Spivak, C. E.; Witkop, B.; Albuquerque, E. X. Anatoxin-a: a novel, potent agonist at the nicotinic receptor. Mol. Pharmacol. 1980, 18, 384-394.
9. Carmichael, W. W.; Biggs, D. F.; Gorham, P. R. Toxicology and Pharmacological Action of Anabaena Flos-Aquae Toxin. Science 1975, 187, 542-544.
10. Rowell, R. R.; Wonnacott, S. Evidence for functional activity of up-regulated nicotine binding sites in rat striatal synaptosomes. J. Neurochem. 1990, 55, 2105-2110.
11. Stolerman, I. P.; Albuquerque, E. X.; Garcha, H. S. Behavioural effects of anatoxin, a potent nicotinic agonist, in rats. Neuropharmacology 1992, 31, 311-314.
12. Lukas, R. J.; Changeux, J.-P.; le_Novere, N.; Albuquerque, E. X.; Balfour, D. J. K.; Berg, D. K.; Bertrand, D.; Chiappinelli, V. A.; Clarke, P. B. S.; Collins, A. C.; Dani, J. A.; Grady, S. A.; Kellar, K. J.; Lindstrom, J. M.; Marks, M. J.; Quik, M.; Taylor, P. W.; Wonnacott, S. International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits. Pharmacol. Rev. 1999, 51, 397-401.
13. Thomas, P.; Stephens, M.; Wilkie, G.; Amar, M.; Lunt, G. G.; Whiting, P.; Gallagher, T.; Pereira, E.; Alkondon, M.; Albuquerque, E. X.; Wonnacott, S. (+)-Anatoxin-a is a potent agonist at neuronal nicotinic acetylcholine receptors. J. Neurochem. 1993, 60, 2308-2311.
14. Jensen, A. A.; Frolund, B.; Liljefors, T.; Krogsgaard-Larsen, P. Neuronal nicotinic acetylcholine receptors: structural revelations, target identifications, and therapeutic inspirations. J. Med. Chem. 2005, 48, 4705-4745.
15. MacAllan, D. R. E., Lunt, G. G., Wonnacott, S., Aracava, Y., Albuquerque, E. X. Methyllycaconitine and anatoxin-a differentiate between nicotinic receptors in vertebrate and invertebrate CNS. FEBS Lett. 1988, 226, 357-363.
16. Dajas-Bailador, F.; Wonnacott, S. Nicotinic acetylcholine receptors and the regulation of neuronal signalling. Trends Pharmacol. Sci. 2004, 25, 317-324.
17. Cassels, B. K.; Bermudez, I.; Dajas, F.; Abin-Carriquiry, J. A.; Wonnacott, S. From ligand design to therapeutic efficacy: the challenge for nicotinic receptor research. Drug Discovery Today 2005, 10, 1657-1665.
18. Devlin, J. P.; Edwards, O. E.; Gorham, P. R.; Hunter, N. R.; Pike, R. K.; Stavric, B. Anatoxin-a, a Toxic Alkaloid from Anabaena-Flos-Aquae Nrc-44h. Can. J. Chem. 1977, 55, 1367-1371.
19. Wonnacott, S.; Swanson, K. L.; Albuquerque, E. X.; Huby, N. J. S.; Thompson, P.; Gallagher, T. Homoanatoxin - a Potent Analog of Anatoxin-a. Biochem. Pharmacol. 1992, 43, 419-423.
20. Skulberg, O. M.; Carmichael, W. W.; Andersen, R. A.; Matsunaga, S.; Moore, R. E.; Skulberg, R. Investigations of a Neurotoxic Oscillatorialean Strain (Cyanophyceae) and Its Toxin - Isolation and Characterization of Homoanatoxin-A. Environ. Toxicol. Chem. 1992, 11, 321-329.
21. Zotou, A.; Jefferies, T. M.; Brough, P. A.; Gallagher, T. Determination of Anatoxin-a and Homoanatoxin in Blue-Green-Algal Extracts by High-Performance Liquid-Chromatography and Gas-Chromatography Mass-Spectrometry. Analyst 1993, 118, 753-758.
22. Takada, N.; Iwatsuki, M.; Suenaga, K.; Uemura, D. Pinnamine, an alkaloidal marine toxin, isolated from Pinna muricata. Tetrahedron Lett. 2000, 41, 6425-6428.
23. Kigoshi, H.; Hayashi, N.; Uemura, D. Stereoselective synthesis of pinnamine, an alkaloidal marine toxin from Pinna muricata. Tetrahedron Lett. 2001, 42, 7469-7471.
24. Hjelmgaard, T.; Sotofte, I.; Tanner, D. Total synthesis of pinnamine and anatoxin-a via a common intermediate. A caveat on the anatoxin-a endgame. J. Org. Chem. 2005, 70, 5688-5697.
25. Schwarz, S.; Kampchen, T.; Tilotta, M. C.; Gundisch, D.; Seitz, G. Synthesis and nicotinic binding studies on enantiopure pinnamine variants with an 8-azabicyclo[3.2.1]octane moiety. Pharmazie 2003, 58, 295-299.
26. Huber, C. S. The Crystal Structure and Absolute Configuration of 2,9-Diacetyl-9-azabicyclo[4,2,1]non-2,3-ene. Acta Crystallogr. Ser. B. 1972, B28, 2577-2582.
27. Namikoshi, M.; Murakami, T.; Fujiwara, T.; Nagai, H.; Niki, T.; Harigaya, E.; Watanabe, M. F.; Oda, T.; Yamada, J.; Tsujimura, S. Biosynthesis and transformation of homoanatoxin-a in the cyanobacterium Raphidiopsis mediterranea Skuja and structures of three new homologues. Chem. Res. Toxicol. 2004, 17, 1692-1696.
28. Hemscheidt, T.; Rapala, J.; Sivonen, K.; Skulberg, O. M. Biosynthesis of Anatoxin-a in Anabaena-Flos-Aquae and Homoanatoxin-a in Oscillatoria-Formosa. J. Chem. Soc., Chem. Commun. 1995, 1361-1362.
29. Namikoshi, M.; Murakami, T.; Watanabe, M. F.; Oda, T.; Yamada, J.; Tsujimura, S.; Nagai, H.; Oishi, S. Simultaneous production of homoanatoxin-a, anatoxin-a, and a new non-toxic 4-hydroxyhomoanatoxin-a by the cyanobacterium Raphidiopsis mediterranea Skuja. Toxicon 2003, 42, 533-538.
30. Gallon, J. R.; Chit, K. N.; Brown, E. G. Biosynthesis of the Tropane-Related Cyanobacterial Toxin Anatoxin-a - Role of Ornithine Decarboxylase. Phytochemistry 1990, 29, 1107-1111.
31. Gallon, J. R.; Kittakoop, P.; Brown, E. G. Biosynthesis of Anatoxin-a by Anabaena-Flos-Aquae - Examination of Primary Enzymatic Steps. Phytochemistry 1994, 35, 1195-1203.
32. Koskinen, A. M. P.; Rapoport, H. Synthetic and Conformational Studies on Anatoxin-a - a Potent Acetylcholine Agonist. J. Med. Chem. 1985, 28, 1301-1309.
33. Campbell, H. F.; Edwards, O. E.; Kolt, R. Synthesis of nor-Anatoxin-a and Anatoxin-a. Can. J. Chem. 1977, 55, 1372-1379.
34. Wegge, T.; Schwarz, S.; Seitz, G. A new and efficient synthetic route to enantiopure (+)-anatoxina from (-)-cocaine hydrochloride. Tetrahedron: Asymmetry 2000, 11, 1405-1410.
35. Zhang, C. M.; Lomenzo, S. A.; Ballay, C. J.; Trudell, M. L. An improved synthesis of (+)-2-tropinone. J. Org. Chem. 1997, 62, 7888-7889.
36. Spivak, C. E.; Waters, J.; Witkop, B.; Albuquerque, E. X. Potencies and channel properties induced by semirigid agonists at frog nicotinic acetylcholine receptors. Mol. Pharmacol. 1983, 23, 337-343.
37. Badio, B.; Daly, J. W. Epibatidine, a potent analgesic and nicotinic agonist. Mol. Pharmacol. 1994, 45, 563-569.
38. Rozental, R.; Aracava, Y.; Scoble, G. T.; Swanson. K. L.; Wonnacott, S.; Albuquerque, E. X. Agonist recognition site of the peripheral acetylcholine receptor ion channel complex differentiates the enantiomers of nicotine. J. Pharmacol. Expt. Ther. 1989, 251, 395-404.
39. Wonnacott, S. Alpha-Bungarotoxin binds to low-affinity nicotine binding sites in rat brain. J. Neurochem. 1986, 47, 1706-1712.
40. Beers, W. H.; Reich, E. Structure and Activity of Acetylcholine. Nature 1970, 228, 917-923.
41. Sheridan, R. P.; Nilakantan, R.; Dixon, J. S.; Venkataraghavan, R. The Ensemble Approach to Distance Geometry - Application to the Nicotinic Pharmacophore. J. Med. Chem. 1986, 29, 899-906.
42. Manallack, D.; Gallagher, T.; Livingstone, D. In Principles in QSAR and Drug Design; Devillers, J., Ed.; Academic Press: London, 1996; Vol. 2. pp 177-208.
43. Glennon, R. A.; Herndon, J. A.; Dukat, M. Epibatidine-Aided Studies toward Definition of a Nicotine Receptor Pharmacophore. Med. Chem. Res. 1994, 6, 465-486.
44. Tonder, J. E.; Olesen, P. H. Agonists at the alpha4beta2 nicotinic acetylcholine receptors: Structure-activity relationships and molecular modelling. Curr. Med. Chem. 2001, 8, 651-674.
45. Tonder, J. E.; Olesen, P. H.; Hansen, J. B.; Begtrup, M.; Pettersson, I. An improved nicotinic pharmacophore and a stereoselective CoMFA-model for nicotinic agonists acting at the central nicotinic acetylcholine receptors labelled by H-3-N-methylcarbamylcholine. J. Comput.-Aided. Mol. Des. 2001, 15, 247-258.
46. Tonder, J. E.; Hansen, J. B.; Begtrup, M.; Pettersson, I.; Rimvall, K.; Christensen, B.; Ehrbar, U.; Olesen, P. H. Improving the nicotinic pharmacophore with a series of (isoxazole)methylene-1-azacyclic compounds: Synthesis, structure-activity relationship, and molecular modeling. J. Med. Chem. 1999, 42, 4970-4980.
47. Glennon, R. A.; Dukat, M. alpha4beta2 nACh receptor pharmacophore models. Bioorg. Med. Chem. Lett. 2004, 14, 1841-1844.
48. Glennon, R. A.; Dukat, M.; Liao, L. Musings on alpha4beta2 nicotinic acetylcholine (nACh) receptor pharmacophore models. Curr. Med. Chem. 2004, 4, 631-644.
49. Manallack, D. T.; Ellis, D. D.; Thompson, P. E.; Gallagher, T.; Livingstone, D. J. Quantitative Structure-Activity Relationships of (+)-Anatoxin-a Derivatives. Natural Prod. Lett. 1994, 4, 121-128.
50. Petersen, J. S.; Fels, G.; Rapoport, H. Chirospecific Syntheses of (+)-Anatoxin and (-)-Anatoxin-a. J. Am. Chem. Soc. 1984, 106, 4539-4547.
51. Sardina, F. J.; Howard, M. H.; Morningstar, M.; Rapoport, H. Enantiodivergent Synthesis of (+)-Anatoxin and (-)-Anatoxin from L-Glutamic Acid. J. Org. Chem. 1990, 55, 5025-5033.
52. Sardina, F. J.; Howard, M. H.; Koskinen, A. M. P.; Rapoport, H. Chirospecific Synthesis of Nitrogen and Side-Chain Modified Analogs of (+)-Anatoxin. J. Org. Chem. 1989, 54, 4654-4660.
53. Howard, M. H.; Sardina, F. J.; Rapoport, H. Chirospecific Syntheses of Nitrogen and Side-Chain Modified Anatoxin Analogs - Synthesis of (1R)-Anatoxinal and (1R)-Anatoxinic Acid-Derivatives. J. Org. Chem. 1990, 55, 2829-2838.
54. Costa, A. C.; Swanson, K. L.; Aracava, Y.; Aronstam, R. S.; Albuquerque, E. X. Molecular effects of dimethylanatoxin on the peripheral nicotinic acetylcholine receptor. J. Pharmacol. Exp. Ther. 1990, 252, 507-516.
55. Kofuji, P.; Aracava, Y.; Swanson, K. L.; Aronstam, R. S.; Rapoport, H.; Albuquerque, E. X. Activation and blockade of the acetylcholine receptor-ion channel by the agonists (+)-anatoxin-a, the N-methyl derivative and the enantiomer. J. Pharmacol. Exp. Ther. 1990, 252, 517-525.
56. Wonnacott, S.; Jackman, S.; Swanson, K. L.; Rapoport, H.; Albuquerque, E. X. Nicotinic pharmacology of anatoxin analogs: II. Side chain structure-activity relationships at neuronal nicotinic ligand binding sites. J. Pharmacol. Exp. Ther. 1991, 259, 387-391.
57. Stevens, D. K.; Krieger, R. I. N-Methylation of anatoxin-a abolishes nicotinic cholinergic activity. Toxicon. 1990, 28, 133-134.
58. Swanson, K. L.; Aronstam, R. S.; Wonnacott, S.; Rapoport, H.; Albuquerque, E. X. Nicotinic pharmacology of anatoxin analogs. I. Side-chain structure-activity relationships at peripheral agonist and noncompetitive antagonist sites. J. Pharmacol. Exp. Ther. 1991, 259, 377-386.
59. Arneric, S. P.; Sullivan, J. P.; Briggs, C. A.; Donnelly-Roberts, D.; Anderson, D. J.; Raszkiewicz, J. L.; Hughes, M. L.; Cadman, E. D.; Adams, P.; Garvey, D. S. et al. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: I. In vitro characterization. J. Pharmacol. Exp. Ther. 1994, 270, 310-318.
60. Thomas, P.; Brough, P. A.; Gallagher, T.; Wonnacott, S. Alkyl-Modified Side-Chain Variants of Anatoxin-a - a Series of Potent Nicotinic Agonists. Drug Dev. Res. 1994, 31, 147-156.
61. Parsons, P. J.; Camp, N. P.; Edwards, N.; Sumoreeah, L. R. Synthesis of (+/-)-Anatoxin-a and Analogues. Tetrahedron 2000, 56, 309-315.
62. Huby, N. J. S.; Thompson, P.; Wonnacott, S.; Gallagher, T. Structural Modification of Anatoxin-a - Synthesis of Model Affinity Ligands for the Nicotinic Acetylcholine-Receptor. J. Chem. Soc., Chem. Commun. 1991, 243-245.
63. Magnus, N. A.; Ducry, L.; Rolland, V.; Wonnacott, S.; Gallagher, T. Direct C-11 functionalisation of anatoxin-a. Application to the synthesis of new ligand-based structural probes. J. Chem. Soc., Perkin Trans. 1 1997, 2313-2318.
64. Thompson, P. E.; Manallack, D. T.; Blaney, F. E.; Gallagher, T. Conformational Studies on (+)-Anatoxin-a and Derivatives. J. Comput.-Aided Mol. Des. 1992, 6, 287-298.
65. Hacksell, U.; Mellin, C. Stereoselectivity of Nicotinic Receptors. Prog. Brain Res. 1989, 79, 95-100.
66. Kanne, D. B.; Ashworth, D. J.; Cheng, M. T.; Mutter, L. C.; Abood, L. G. Synthesis of the First Highly Potent Bridged Nicotinoid - 9-Azabicyclo[4.2.1] nona[2,3-c]pyridine (Pyrido[3,4-b]homotropane). J. Am. Chem. Soc. 1986, 108, 7864-7865.
67. Kanne, D. B.; Abood, L. G. Synthesis and Biological Characterization of Pyridohomotropanes - Structure-Activity-Relationships of Conformationally Restricted Nicotinoids. J. Med. Chem. 1988, 31, 506-509.
68. Gundisch, D.; Kampchen, T.; Schwarz, S.; Seitz, G.; Siegl, J.; Wegge, T. Syntheses and evaluation of pyridazine and pyrimidine containing bioisosteres of (+/-)-pyrido[3.4-b]homotropane and pyrido[3.4-b]tropane as novel nAChR ligands. Bioorg. Med. Chem. 2002, 10, 1-9.
69. Brough, P. A.; Gallagher, T.; Thomas, P.; Wonnacott, S.; Baker, R.; Malik, K. M. A.; Hursthouse, M. B. Synthesis and X-Ray Crystal-Structure of 2-Acetyl-9-Azabicyclo[4.2.1]nonan-3-one - a Conformationally Locked s-Cis Analog of Anatoxin-a. J. Chem. Soc., Chem. Commun. 1992, 1087-1089.
70. Hernandez, A.; Rapoport, H. Conformationally Constrained Analogs of Anatoxin - Chirospecific Synthesis of s-Trans Carbonyl Ring-Fused Analogs. J. Org. Chem. 1994, 59, 1058-1066.
71. Holladay, M. W.; Dart, M. J.; Lynch, J. K. Neuronal nicotinic acetylcholine receptors as targets for drug discovery. J. Med. Chem. 1997, 40, 4169-4194.
72. Le Novere, N.; Grutter, T.; Changeux, J. P. Models of the extracellular domain of the nicotinic receptors and of agonist- and Ca2+-binding sites. Proc. Natl. Acad. Sci. U S A. 2002, 99, 3210-3215.
73. Wright, E.; Gallagher, T.; Sharples, C. G. V.; Wonnacott, S. Synthesis of UB-165: A novel nicotinic ligand and anatoxin-a/epibatidine hybrid. Bioorg. Med. Chem. Lett. 1997, 7, 2867-2870.
74. Sharples, C. G.; Kaiser, S.; Soliakov, L.; Marks, M. J.; Collins, A. C.; Washburn, M.; Wright, E.; Spencer, J. A.; Gallagher, T.; Whiteaker, P.; Wonnacott, S. UB-165: a novel nicotinic agonist with subtype selectivity implicates the alpha4beta2* subtype in the modulation of dopamine release from rat striatal synaptosomes. J. Neurosci. 2000, 20, 2783-2791.
75. Cao, Y. J.; Surowy, C. S.; Puttfarcken, P. S. Nicotinic acetylcholine receptor-mediated [3H]dopamine release from hippocampus. J. Pharmacol. Exp. Ther. 2005, 312, 1298-1304.
76. Sharples, C. G. V.; Karig, G.; Simpson, G. L.; Spencer, J. A.; Wright, E.; Millar, N. S.; Wonnacott, S.; Gallagher, T. Synthesis and pharmacological characterization of novel analogues of the nicotinic acetylcholine receptor agonist (+/-)-UB-165. J. Med. Chem. 2002, 45, 3235-3245.
77. Gohlke, H.; Gundisch, D.; Schwarz, S.; Seitz, G.; Tilotta, M. C.; Wegge, T. Synthesis and nicotinic binding studies on enantiopure diazine analogues of the novel (2-chloro-5-pyridyl)-9-azabicyclo[4.2.1]non-2-ene UB-165. J. Med. Chem. 2002, 45, 1064-1072.
78. Karig, G.; Large, J. M.; Sharples, C. G. V.; Sutherland, A.; Gallagher, T.; Wonnacott, S. Synthesis and nicotinic binding of novel phenyl derivatives of UB-165. Identifying factors associated with alpha7 selectivity. Bioorg. Med. Chem. Lett. 2003, 13, 2825-2828.
79. Sutherland, A.; Gallagher, T.; Sharples, C. G. V.; Wonnacott, S. Synthesis of two fluoro analogues of the nicotinic acetylcholine receptor agonist UB-165. J. Org. Chem. 2003, 68, 2475-2478.